Glenmark Pharmaceuticals gains on receiving USFDA approval for generic version of Xylocaine ointment

12 Sep 2016 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 900.15, up by 4.40 points or 0.49% from its previous closing of Rs. 895.75 on the BSE.

The scrip opened at Rs. 892.00 and has touched a high and low of Rs. 898.55 and Rs. 885.00 respectively. So far 12,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1074.90 on 06-Oct-2015 and a 52 week low of Rs. 671.50 on 12-Feb-2016.

Last one week high and low of the scrip stood at Rs. 915.00 and Rs. 834.35 respectively. The current market cap of the company is Rs. 25,399.71 crore.

The promoters holding in the company stood at 46.48%, while Institutions and Non-Institutions held 42.06% and 11.46% respectively.

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Lidocaine Ointment USP, 5%, the generic version of Xylocaine Ointment, 5% of AstraZeneca. The Xylocaine Ointment, 5% market achieved annual sales of approximately $373.0 million, according to IMS Health sales data for the twelve month period ending July 2016.

The pharma major has been recently granted final approval by the USFDA for Triamcinolone Acetonide Cream USP, 0.1%, the generic version of Kenalog Cream, 0.1% of Delcor Asset Corporation (which is no longer being marketed in the United States).

Glenmark’s current portfolio consists of 109 products authorized for distribution in the US marketplace and 62 ANDA’s pending approval with the US FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.


Glenmark Pharma Share Price

1960.00 5.20 (0.27%)
19-Dec-2025 11:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1744.80
Dr. Reddys Lab 1275.90
Cipla 1506.70
Zydus Lifesciences 913.05
Lupin 2121.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×